Cardiovascular Magnetic Resonance in the Oncology Patient

Patients with or receiving potentially cardiotoxic treatment for cancer are susceptible to developing decrements in left ventricular mass, diastolic function, or systolic function. They may also experience valvular heart disease, pericardial disease, or intracardiac masses. Cardiovascular magnetic r...

Descripción completa

Detalles Bibliográficos
Autores principales: Jordan, Jennifer H., Todd, Ryan M., Vasu, Sujethra, Hundley, W. Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242266/
https://www.ncbi.nlm.nih.gov/pubmed/30092971
http://dx.doi.org/10.1016/j.jcmg.2018.06.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242266/
https://www.ncbi.nlm.nih.gov/pubmed/30092971
http://dx.doi.org/10.1016/j.jcmg.2018.06.004

Ejemplares similares